Cohort study reveals combined effects of depression and osteoporosis on mortality, indicating significant health risks.
Depression and osteoporosis are significant global health issues. Depression affects mental well-being and imposes social and economic burdens, while osteoporosis impacts bone health and raises fracture risk. However, their effects on cardiovascular disease (CVD) mortality and all-cause mortality remain unclear. This study examines their combined impact on cardiovascular and all-cause mortality. We used National Health and Nutrition Examination Survey data from 2005 to 2010, 2013 to 2014, and 2017 to 2018 (n = 19,282; weighted population 155,470,483). Depression was assessed via Patient Health Questionnaire-9, and osteoporosis through dual-energy X-ray absorptiometry scans. Mortality data came from the National Death Index. Participants were categorized into 4 groups based on depression and osteoporosis status. Cox models and Kaplan–Meier analysis were used to assess mortality risk. The primary outcomes were CVD mortality and all-cause mortality. During a median 122-month follow-up, there were 2384 all-cause deaths and 581 CVD deaths. The Dep+/OP+ group had the highest all-cause mortality risk (hazard ratio = 2.80, 95% confidence intervals: 1.92–4.08) and CVD mortality risk (hazard ratio = 2.03, 95% confidence intervals: 1.21–3.39). Compared to the Dep−/OP− group, the Dep−/OP+ and Dep+/OP− groups also had elevated risks. The combination of depression and osteoporosis significantly increases CVD and all-cause mortality risks, particularly in younger individuals and males. These conditions may share biological pathways that increase mortality risk, highlighting the need for integrated clinical management.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: